FIELD: medicine, pharmaceutics.
SUBSTANCE: claimed group of inventions relates to medicine, namely to immunology and virology, and deals with inhibition of production or enhancement of elimination of protein P24. For this purpose an activated-potentiated form of antibodies to CD4 receptor is used.
EFFECT: introduction of the claimed means in experiments "in vitro" ensures considerable reduction of protein P24 content after infecting cells with strain HIV-ILAI.
6 cl, 1 ex
Authors
Dates
2014-05-27—Published
2010-08-06—Filed